Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinoma.
BACKGROUND: /purpose. RESULTS: High-cfDNA independently predicted shorter OS (median 13.0 vs.
BACKGROUND: /purpose. RESULTS: High-cfDNA independently predicted shorter OS (median 13.0 vs.
What the study was
- Study design
- Cohort study
- Sample size
- 17
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Hepatology international
Why it surfaced
Relevant Early cancer detection study (early cancer detection relevance) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.